Bryn Mawr Capital Management LLC Acquires Shares of 3,900 Teleflex Incorporated (NYSE:TFX)

Bryn Mawr Capital Management LLC acquired a new stake in Teleflex Incorporated (NYSE:TFX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,900 shares of the medical technology company’s stock, valued at approximately $694,000.

Several other hedge funds also recently added to or reduced their stakes in TFX. Creative Planning raised its position in Teleflex by 7.8% in the third quarter. Creative Planning now owns 5,671 shares of the medical technology company’s stock valued at $1,403,000 after purchasing an additional 412 shares during the period. Blue Trust Inc. lifted its stake in shares of Teleflex by 47.2% in the third quarter. Blue Trust Inc. now owns 312 shares of the medical technology company’s stock worth $77,000 after acquiring an additional 100 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Teleflex by 41.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock valued at $6,010,000 after purchasing an additional 7,132 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in Teleflex by 2.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 6,637 shares of the medical technology company’s stock valued at $1,641,000 after purchasing an additional 153 shares in the last quarter. Finally, International Assets Investment Management LLC increased its holdings in Teleflex by 29,127.3% during the 3rd quarter. International Assets Investment Management LLC now owns 3,215 shares of the medical technology company’s stock worth $795,000 after purchasing an additional 3,204 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

TFX stock opened at $175.43 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a market cap of $8.15 billion, a P/E ratio of 34.88, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $165.62 and a 12-month high of $249.90. The stock’s 50 day simple moving average is $177.07 and its 200 day simple moving average is $207.80.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial reduced their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Royal Bank of Canada reduced their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.